Enzolytics Inc (ENZC)

[bigtalan]

What do you think people are confused on? We have been waiting for the start of Africa for awhile now. As the example I posted they were already redoing the trial in the EU and people are questing where the results are from the 2nd trial. Now Enzolytics are saying they will use data from Africa and start a trial in EU 2023/2024. We all have read what was stated.

CLINICAL RESULTS AND NEW TRIALS
The therapy has been tested already in a clinical setting in the EU, but due to interference with costs in manufacturing and a lack of financing, the clinical trial couldn’t be completed. However, they do have data, and this data will show investors how the current clinical trial should readout.


Now that the Bulgarian Drug Administration (BGA) has been supplanted by the European Medicines Agency (EMA), the company is conducting a trial under EMA guidelines. This is great for Enzolytics because approval of ITV-1 under the EMA can lead to FDA approval due to the EU Recognition Treaty. And, this time, the clinical trial should be completed because Enzolytics has already secured a partner: Partnership International Medical Partners, Ltd. (IMPL), which is a 50/50 joint venture between Enzolytics and Bulgarian principals. Enzolytics is producing the ITV-1, while the other party is funding the clinical trials.

here is the article
https://insiderfinancial.com/enzolytics-enzc-takes-on-hiv-heavyweight-gilead-sciences/181723/#:~:text=Now%20that%20the%20Bulgarian%20Drug%20Administration%20%28BGA%29%20has,FDA%20approval%20due%20to%20the%20EU%20Recognition%20Treaty